Increased Stimulant Prescribing Following the COVID-19 Pandemic - Rhode Island, 2017-2021

R I Med J (2013). 2023 Jul 5;106(6):52-55.

¹ Prescription Drug Monitoring Program (PDMP) Epidemiologist, Center for Health Data and Analysis (CHDA) at RIDOH.
² Substance Use Epidemiologist, CHDA at RIDOH.
³ Assistant Professor Emergency Medicine at Alpert Medical School of B.
⁴ Prescription Drug Monitoring Program (PDMP) Health Research Project Director at RIDOH.
⁵ Prescription Drug Monitoring Program (PDMP) Chief Health Program Evaluator and PharmD Academic Detailer at RIDOH.
⁶ Substance Use Epidemiology Program Team Lead, CHDA at RIDOH.

No abstract available

MeSH terms